top of page

FDA approves expanded label for Namzaric in Alzheimer’s disease

The US Food and Drug Administration (FDA) has approved an expanded label for Namzaric.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page